Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
---|---|---|---|
USD 4.16 Billion | USD 6.36 Billion | 4.82% | 2023 |
According to a report from Zion Market Research, the global Urinalysis Market was valued at USD 4.16 Billion in 2023 and is projected to hit USD 6.36 Billion by 2032, with a compound annual growth rate (CAGR) of 4.82% during the forecast period 2024-2032.
This report explores market strengths, weakness, opportunities, and threats. It also provides valuable insights into the market's growth drivers, challenges, and the future prospects that may emerge in the Urinalysis Market industry over the next decade.
The urinalysis includes certain screening tests that can help in detection of some of the common diseases. It may be used to screen for and/or help diagnose conditions such as urinary tract infections, kidney disorders, liver problems, diabetes or other metabolic conditions. A urinalysis includes a number of microscopic, chemical and visual examinations used to detect cells, cell fragments and various other substances such as casts or crystals in the urine associated with the various conditions listed above. Urinalysis helps in detection of abnormalities which might require additional testing and follow-up investigation. It is often seen that substances such as either glucose or protein will appear in the urine before the patient becomes aware of his illness. Thus, urinalysis plays an important role in monitoring health conditions. The urinalysis is usually carried out as pregnancy check-up, routine medical check-up, pre-surgery preparation, or on hospital admission to treat various disorders.
Growing incidences of target disease such as kidney disorders, liver problems, and diabetes are expected to be the major driver for the global urinalysis market. In addition, growing geriatric population coupled along with the introduction of technologically advanced diagnostics is expected to trigger the growth of urinalysis industry in the coming years. The geriatric population requires regular urinalysis for detection of an array of age-related diseases. However, strict government regulations implied on this industry and lack of healthcare infrastructure may pose the challenge to urinalysis market. Nevertheless, the huge base of the target population and unmet clinical needs in under developed countries is expected to act an opportunity for urinalysis market in near future.
COVID-19 pandemic has caused both economic and social disruption. Owing to COVID-19, the other minor disease market have been severely affected. As with the increasing COVID-19 the peoples have reduced the check-ups and diagnosis of minor diseases owing to the fear of COVID-19. People have minimized the routine check-ups of UTIs and others owing to COVID situations in the hospital. Lockdown in various countries also led to decrease medical tourism impacting the market growth
Urinalysis Market is expected to grow tremendously owing to growing prevalence of kidney disease sand urinary tract infections. The growing occurrence of target diseases, such as Urinary Tract Infections (UTI), kidney diseases, and diabetes with the increase in the new advanced technology, rapid, non-invasive, and user-friendly tools for urinalysis are projected to be the major growth drivers of this market. As now a days, there is vast increase of the diseases in the growing population, which is the reason of the increasing awareness regarding the regular health check-ups which is anticipated to increase the growth of the urinalysis market.
The increased technologically advanced diagnostic can be the one of the major growth factor for the Urinalysis Market. Also, growing adaption of point-of-care Urinalysis system is also expected to boost the Urinalysis Market.
On the other hand, the lack of suitable healthcare substructure, limited skilled practitioner, and poor reimbursement policies may slow the growth of the market.
Based on product, urinalysis market has been segmented into consumables, instruments. Urinalysis market was dominated by consumables segment which accounted for largest revenue share across the globe. Reagents, dipstick, and disposables are the major consumables used in urinalysis. Whereas, technological advancements in the instruments segment are estimated to drive the growth of this segment over the forecast period.
The urinalysis market is segmented into the application such as kidney diseases, hypertension, urinary tract infection, diabetes, liver diseases and other applications. In terms of demand, the urinary tract infections (UTI) application segment dominated the market in 2015. Urinary tract infections (UTI) application segment hold more than 20% share of urinalysis market. Kidney diseases, hypertension, and diabetes are other major application segments of urinalysis market. While, diabetes is expected to be the fastest growing application segments of urinalysis market.
Report Attributes | Report Details |
---|---|
Report Name | Urinalysis Market |
Market Size in 2023 | USD 4.16 Billion |
Market Forecast in 2032 | USD 6.36 Billion |
Growth Rate | CAGR of 4.82% |
Number of Pages | 150 |
Key Companies Covered | Roche Diagnostics, ACON Laboratories Inc., Alere Inc., Teco Diagnostics, Olympus Corp., Fujifilm Holding Corp., Mindray, Siemens Healthcare, and Bio-Rad laboratories |
Segments Covered | By Product, By Application, And By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
North America dominates the global market. Over the forecast period North America is expected to grow tremendously. Since the previous few decades there is tremendous increase in the use of urine analysis. Moreover, urine analysis have become a part of any general health check up in the past decade. Increase in the research activities regarding the urine analysis have resulted in the formation point of care systems. Also, growing awareness of personalized medicine and automated devices installation in the large hospitals and laboratories is expected to elevate the growth of the market.
Asia Pacific is anticipated to have a fastest growth with a CAGR of around 10.2% during the forecast period. The growing technology and rate regarding the urine analyzers, and the existence of local urine analyzer manufacturers, such as Mindray and Urit medical with a abundant number of population with unmet clinical needs are expected to strengthen the market growth over the forecast period.
Some of the major companies operating in the Urinalysis Market are:
By Product
By Application
By Region
FrequentlyAsked Questions
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed